FindTrial
Sign In

A pilot study of internet cognitive therapy for social anxiety disorder in Japan

An evaluation of the feasibility, acceptability, and preliminary efficacy of internet-delivered cognitive therapy for social anxiety disorder in Japan: A single-group pilot trial - A pilot study of internet cognitive therapy for social anxiety disorder in Japan

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000044810
Enrollment
16
Registered
2021-07-10
Start date
2021-07-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Social anxiety disorder

Interventions

Therapist-supported internet-delivered cognitive therapy (14-16 weeks, N=12-16)

Sponsors

University of Miyazaki
Lead Sponsor
Fukunaga Internal and Neuropsychiatry Clinic (Miyazaki), Wakakusa Hospital (Miyazaki), International University of Health and Welfare Narita Hospital (Chiba), Higashi Omiya Mental Clinic (Saitama), Kokoro no Clinica OASIS (Miyagi), Chiba University Hospital (Chiba), Akasaka Clinic for Psychiatry and Psychosomatic Medicine (Warakukai Medical Corp) (Tokyo), Gokiso Kokoro no Clinic (Aichi), Gokiso Counseling Office (Aichi)
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Diagnosis of social anxiety disorder based on DSM-5 Informed consent given Aged 18 years or over Able to access the internet and use an appropriate device Regularly meet their primary psychiatrist to monitor safety and risk

Exclusion criteria

Exclusion criteria: Currently receiving any other psychological intervention Previously received cognitive/behavioural therapy for social anxiety disorder Intellectual disability or intellectual developmental disorder Current alcohol or substance dependence Presence or suspected presence of psychosis, bipolar disorder or serious personality disorder Suicidal intent or recurrent self-harming behavior Neurologic or neuropsychiatric disorder that adversely affects the cognitive performance

Design outcomes

Primary

MeasureTime frame
Liebowitz Social Anxiety Scale (LSAS) (self-report) [Pre, Mid, Post, 3-mo Follow-up]—

Secondary

MeasureTime frame
Taijin Kyofusho Scale (TKS Scale) [Pre, Mid, Post, 3-mo Follow-up] Patient Health Questionnaire-9 (PHQ-9) [Pre, Mid, Post, 3-mo Follow-up] Generalized Anxiety Disorder-7 (GAD-7) [Pre, Mid, Post, 3-mo Follow-up] Social Participation and Satisfaction Scale (SPSS) [Pre, Mid, Post, 3-mo Follow-up] Work and Social Adjustment Scale (WSAS) [Pre, Mid, Post, 3-mo Follow-up] Adverse event [Pre, Mid, Post, 3-mo Follow-up] Weekly process assessment: LSAS, PHQ-9, GAD-7, WSAS, Social Phobia Weekly Summary Scale (SPWSS), Social Cognitions Questionnaire (SCQ)—

Countries

Japan

Contacts

Public ContactNaoki Yoshinaga

University of Miyazaki School of Nursing, Faculty of Medicine

naoki-y@med.miyazaki-u.ac.jp0985-85-9784

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026